thyroid
cancer
common
malign
endocrinerel
tumor
recent
year
thyroid
cancer
well
concern
rapid
rise
firstlin
drug
appli
type
diabet
mellitu
metformin
contribut
stabil
blood
glucos
level
inhibit
gluconeogenesi
reduc
hepat
interestingli
applic
metformin
sharpli
decreas
incid
tumor
diseas
suppress
growth
malign
cell
enhanc
therefor
metformin
may
exert
potenti
antitumor
role
expect
adjuv
drug
treatment
thyroid
cancer
uniqu
transmembran
receptor
belong
famili
lowdens
lipoprotein
receptor
ldlr
highli
similar
member
ldlr
famili
multiligand
receptor
interact
lipoprotein
vitaminbind
protein
hormon
enzym
base
complementlik
sequenc
thu
particip
transmembran
transport
reabsorpt
multipl
mutat
gene
close
relat
plasma
cholesterol
lowdens
lipoprotein
therefor
abl
regul
lipoprotein
metabol
cjun
ntermin
kinas
jnk
signal
pathway
one
critic
member
mitogenactiv
protein
kinas
mapk
jnk
mainli
express
cytoplasm
activ
cytoplasm
jnk
rapidli
transloc
nucleu
activ
transcript
factor
cjun
result
abund
apoptosisrel
gene
meanwhil
inflammatori
respons
activ
paper
mainli
explor
regulatori
effect
metformin
prolif
apoptot
chang
cell
involv
jnk
pathway
human
thyroid
cancer
cell
cultur
roswel
park
memori
institut
rpmi
hyclon
south
logan
ut
usa
contain
fetal
bovin
serum
fb
gibco
rockvil
md
usa
penicillin
mgml
streptomycin
incub
cultur
cell
display
monolay
growth
cell
passag
conduct
trypsin
one
hundr
microlit
cell
suspens
appli
plate
cultur
overnight
day
cell
treat
differ
dose
metformin
differ
time
point
absorb
nm
record
appoint
time
point
use
kit
dojindo
laboratori
kumamoto
japan
depict
viabil
curv
cell
wash
phosphatebuff
salin
pb
twice
centrifug
rmin
min
prepar
suspens
cell
suspens
dilut
bind
buffer
incub
annexin
v
dark
min
propidium
iodid
pi
dark
anoth
min
centrifug
rmin
precipit
dissolv
bind
buffer
subject
flow
cytometri
extract
total
rna
cell
perform
use
trizol
reagent
invitrogen
carlsbad
ca
usa
rna
subject
revers
transcript
extract
cdna
appli
pcr
use
sybr
green
method
takara
tokyo
japan
primer
sequenc
follow
f
r
glyceraldehyd
dehydrogenas
gapdh
f
r
total
protein
extract
cell
use
radioimmunoprecipit
assay
ripa
lysi
butter
quantifi
bicinchonin
acid
bca
method
beyotim
shanghai
china
protein
sampl
load
electrophoresi
transfer
polyvinyliden
fluorid
pvdf
membran
millipor
billerica
usa
block
nonspecif
antigen
skim
milk
hr
membran
subject
incub
primari
secondari
antibodi
band
expos
chemiluminesc
ecl
reagent
analyz
imag
softwar
nih
bethesda
md
usa
cell
detach
trypsin
prepar
suspens
fifti
pmol
transfect
vector
lipofectaminetm
invitrogen
carlsbad
ca
usa
respect
dilut
mainten
room
temperatur
mix
let
stand
anoth
min
subsequ
mixtur
appli
suspens
transfect
cell
h
harvest
function
experi
statist
product
servic
solut
spss
ibm
armonk
ny
usa
use
data
analys
data
express
mean
standard
deviat
differ
among
group
statist
evalu
use
student
ttest
compar
two
group
oneway
analysi
varianc
anova
compar
two
group
p
consid
statist
signific
cell
treat
mm
metformin
h
respect
assay
result
reveal
viabil
concentrationdepend
decreas
either
h
treatment
figur
addit
apoptot
rate
cell
treat
mm
metformin
h
gradual
increas
figur
data
support
abil
metformin
attenu
viabil
induc
apoptosi
cell
treatment
mm
metformin
h
protein
mrna
level
downregul
manifest
relationship
figur
b
clarifi
involv
jnk
pathway
metforminmedi
progress
thyroid
cancer
protein
level
determin
western
blot
protein
level
cell
concentrationdepend
downregul
metformin
treatment
figur
howev
protein
level
remain
unchang
specul
involv
inactiv
jnk
pathway
subsequ
construct
transfect
effect
downregul
mrna
protein
level
cell
show
pronounc
transfect
efficaci
figur
b
transfect
markedli
revers
inhibitori
effect
metformin
protein
level
cell
figur
moreov
decreas
viabil
metformintr
cell
partial
revers
overexpress
figur
verifi
respons
metformininduc
viabil
suppress
jnk
pathway
inactiv
retrospect
epidemiolog
studi
conduct
evan
et
point
applic
metformin
markedli
reduc
incid
malign
tumor
patient
diabet
later
tumorsuppressor
effect
metformin
well
concern
relev
studi
demonstr
metformin
treatment
suppress
tumor
growth
elev
complet
remiss
rate
prolong
diseasefre
surviv
patient
thyroid
cho
et
suggest
applic
differ
dose
metformin
reduc
tumor
volum
suppress
tumor
cell
growth
tumorbear
nude
mice
recent
studi
metformin
like
drug
aicar
affect
cancer
cell
prolifer
turn
effect
creat
cell
death
cancer
cell
via
activ
ampk
paper
metformin
treatment
markedli
inhibit
prolif
abil
induc
apoptosi
cell
furthermor
level
downregul
jnk
pathway
activ
metformin
applic
previou
studi
shown
mainli
involv
regul
lipoprotein
transport
activ
lowdens
lipoprotein
receptor
activ
lipid
metabol
process
lipoprotein
transport
coronari
vasculatur
develop
aorta
develop
cell
prolifer
ventricular
septum
develop
clathrinco
vesicl
membran
lysosom
etc
signific
etiolog
acut
myocardi
jnk
pathway
extens
involv
cellular
behavior
dysregul
consid
link
diseas
cell
gastric
cancer
cell
jnk
induc
apoptosi
mitochondri
pathway
trigger
cytochrom
releas
cytoplasm
initi
apoptot
besid
metformin
abl
activ
ampk
perk
capabl
suppress
mitosi
prolifer
thyroid
cancer
stem
cell
induc
find
illustr
metformin
treatment
inactiv
jnk
pathway
cell
could
abolish
overexpress
collect
metformin
may
benefici
inhibit
progress
thyroid
cancer
downregul
inactiv
jnk
pathway
find
provid
new
direct
clinic
treatment
thyroid
cancer
metformin
treatment
suppress
prolif
abil
induc
apoptosi
cell
downregul
block
jnk
pathway
